NCT05923684Recruiting
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Natural Language Processing-Based Feedback to Improve Physician Risk Communication and Informed Shared Decision Making in Men With Clinically Localized Prostate Cancer
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
In this pilot study, the investigators will show feasibility of the NLP-based feedback system in 20 consultations of men with newly diagnosed prostate cancer. The investigators will recruit from the practices of up to 10 physicians who typically see these patients. The investigators will report the top five sentences from each consultation across key content areas (cancer prognosis, life expectancy, erectile dysfunction, urinary incontinence, and irritative urinary symptoms) to both patients and physicians within 2 weeks of the consultation.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 24 May 2023
- Start date
- Nov 2023
- Primary completion date
- Jul 2027
- Lead sponsor
- Cedars-Sinai Medical Center
- Diseases
- Prostate cancer
- NCT number
- NCT05923684
What you commit to
- Study type: Interventional
- Planned participants: 30
- From Nov 2023 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects with difficulty communicating or dementia;
- Men with locally advanced or metastatic prostate cancer;
- Men who have already been treated for clinically localized prostate cancer
Age
- Under 18 years of age;
Other
- Non-English speakers, given that our NLP-based tools cannot be used with languages other than English;
Who the study is looking for
- Men undergoing initial treatment consultation for clinically localized prostate cancer;
- Men with upgraded prostate cancer on active surveillance considering conversion to definitive local therapy.
- Cedars-Sinai patient.
- Ability to read and write in English.
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cedars-Sinai Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.